IL2RA and myeloid sarcoma: Homozygous risk allele carriers (T) for the MS-associated SNP rs2104286 have reduced STAT5 phosphorylation (18), higher expression of the IL2RA gene in MS patients and an increased level of soluble IL-2Rα (sIL-2Rα) in both MS and HS (19, 20).